Vir Biotechnology (VIR) Invested Capital (2019 - 2025)

Vir Biotechnology (VIR) has 5 years of Invested Capital data on file, last reported at $17.5 million in Q1 2025.

• For the quarter ending Q1 2025, Invested Capital changed N/A year-over-year to $17.5 million; the trailing twelve-month figure through Dec 2025 stood at $17.5 million (up 8.97% YoY), and the FY2024 full-year result was $16.1 million, changed N/A from the prior year.
• Invested Capital improved to $17.5 million in Q1 2025, from $16.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $68.5 million in Q3 2021 to a low of $16.1 million in Q4 2024.
• A 3-year average of $30.5 million and a median of $24.4 million in 2021 frame the typical range for Invested Capital.
• Peak annual rise in Invested Capital reached 457.45% in 2021, while the deepest fall reached 128.04% in 2021.
• Tracing VIR's Invested Capital over 3 years: stood at $68.5 million in 2021, then tumbled by 76.55% to $16.1 million in 2024, then climbed by 8.97% to $17.5 million in 2025.
• Business Quant data shows VIR's Invested Capital at $17.5 million in Q1 2025, $16.1 million in Q4 2024, and $68.5 million in Q3 2021.